Masimo (MASI) to Release Earnings on Thursday

Masimo (NASDAQ:MASI) is projected to release its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of $1.41 per share and revenue of $407.9730 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 4:30 PM ET.

Masimo Stock Performance

Shares of Masimo stock opened at $175.25 on Tuesday. The company has a market capitalization of $9.41 billion, a PE ratio of -16.63, a P/E/G ratio of 1.77 and a beta of 1.26. The company has a 50-day simple moving average of $139.89 and a two-hundred day simple moving average of $143.22. Masimo has a one year low of $125.94 and a one year high of $194.88. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.92 and a current ratio of 2.84.

Hedge Funds Weigh In On Masimo

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Global Retirement Partners LLC purchased a new stake in Masimo during the 4th quarter valued at about $27,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Masimo during the fourth quarter worth about $28,000. Los Angeles Capital Management LLC acquired a new stake in shares of Masimo during the fourth quarter worth about $31,000. Caitong International Asset Management Co. Ltd purchased a new stake in Masimo in the fourth quarter valued at approximately $38,000. Finally, Advisory Services Network LLC acquired a new position in Masimo in the 3rd quarter worth approximately $46,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Stifel Nicolaus set a $180.00 price objective on Masimo in a report on Tuesday, February 17th. Bank of America began coverage on Masimo in a research report on Monday, November 17th. They issued a “neutral” rating and a $162.00 price objective for the company. Finally, Wells Fargo & Company lowered Masimo from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $190.00 to $180.00 in a research report on Wednesday, February 18th. One investment analyst has rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $181.17.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.